Revenue | ₹22.45Cr |
Net Profits | ₹0.76Cr |
Net Profit Margins | 3.39% |
Godavari Drugs Ltd’s revenue fell -24.28% since last year same period to ₹22.45Cr in the Q3 2025-2026. On a quarterly growth basis, Godavari Drugs Ltd has generated -17.71% fall in its revenue since last 3-months.
Godavari Drugs Ltd’s net profit fell -1.3% since last year same period to ₹0.76Cr in the Q3 2025-2026. On a quarterly growth basis, Godavari Drugs Ltd has generated -24% fall in its net profits since last 3-months.
Godavari Drugs Ltd’s net profit margin jumped 30.36% since last year same period to 3.39% in the Q3 2025-2026. On a quarterly growth basis, Godavari Drugs Ltd has generated -7.65% fall in its net profit margins since last 3-months.
The revenue for Godavari Drugs Ltd in the Q3 results 2025 was ₹22.45Cr.
The net profit for Godavari Drugs Ltd in the Q3 results 2025 was ₹0.76Cr.
The net profit margin for Godavari Drugs Ltd in the Q3 results 2025 was 3.39%.
The revenue for Godavari Drugs Ltd in the Q3 results 2024 was ₹29.65Cr.
The net profit for Godavari Drugs Ltd in the Q3 results 2024 was ₹0.77Cr.
The net profit margin for Godavari Drugs Ltd in the Q3 results 2024 was 2.60%.